Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Diabetic Neuropathy Clinical Trials

A listing of Diabetic Neuropathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (12) clinical trials

This study will see if an investigational drug called NYX-2925 can reduce the nerve pain in the legs and feet associated with painful diabetic peripheral neuropathy.

Phase

Do you suffer from persistent burning, throbbing, or tingling pain in your feet? Are you currently taking medication for this pain?

Phase

Currently enrolling in your area! Is your current neuropathic pain treatment providing adequate control of your pain? If NOT, you may interested in learning more about a clinical research trial of an investigational medication that is being evaluated for the treatment of diabetes painful neuropathy. You may be eligible to ...

Phase

Do you have DIABETES? Do You Suffer from PAIN in Your Feet or Legs? The primary purpose of this study is to research the investigational drug, LY545694, for patients with painful diabetic neuropathy (nerve damage that can cause numbness or painful tingling in parts of the body). Qualified Participants Must: ...

Phase

Local doctors are looking for people with Diabetic Peripheral Neuropathy for clinical research studies of an investigational medication.  Diagnosis of Type II Diabetes is required. Compensation provided for time and travel!

Phase

Do you have Type 2 Diabetes with painful diabetic neuropathy in your legs or feet? You may qualify for a research study at Advanced Clinical Research. To learn more, call Advanced Clinical Research at 208-955-9030 or visit www.acridaho.com

Phase

The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

The investigators propose to examine the effects of GLP-1 receptor agonist Liraglutide on autonomic sudomotor function and endothelial and neurovascular functions as well as markers of inflammation in patients with type 2 diabetes mellitus (T2DM). The primary objective will be changes in peripheral autonomic function using sudorimetry (Sudoscan) after 1 ...

Phase

Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes

To compare the efficacy of two dosages (600mg/day and 1200mg/day) of bicifadine SR with placebo for 14 weeks in reduction of chronic neuropathic patin (measured by a daily rating of pain intensity) associated with diabetic periperal neuropathy in adult outpatients. To compare the tolerability of two dosages of bicifadine SR ...

Phase

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

This is a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to assess the efficacy and safety of NYX-2925 in subjects with neuropathic pain associated with diabetic peripheral neuropathy. The study will be a 6 to 9-week study, including a 1 to 4-week (dependent on duration of washout period) Screening Period, followed ...

Phase

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Treatment induced neuropathy of diabetes (TIND), also referred to as insulin neuritis, is thought to be a rare iatrogenic cause of neuropathy that occurs in the setting of rapid glycemic control in individuals with a history of prolonged hyperglycemia. In a recent paper, the investigators reported that a systematic review ...

Phase